Lv1
20 积分 2023-09-06 加入
The gut-heart axis in heart failure: a systematic review and meta-analysis of gut microbiota and metabolites
1个月前
已完结
Neutrophil serine proteases NE and PR3 controlled by the miR-223/STAT3 axis potentiate MASH and liver fibrosis
3个月前
已完结
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
8个月前
已完结
Gut Microbiome Interventions: From Dysbiosis to Next-Generation Probiotics (NGPs) for Disease Management
9个月前
已完结
The pathophysiology of MASLD: an immunometabolic perspective
9个月前
已完结
First US drug approved for a liver disease surging around the world
9个月前
已完结
Mechanisms and therapeutic insights into MASH-associated fibrosis
9个月前
已完结
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis
9个月前
已完结
Serum amyloid A1–induced intrahepatic regulatory T-cell dysfunction drives autoimmune hepatitis progression
11个月前
已完结
GSDME promotes MASLD by regulating pyroptosis, Drp1 citrullination-dependent mitochondrial dynamic, and energy balance in intestine and liver
1年前
已完结